Isodiol International Inc ISOLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.03 / $0.05
- Market Cap
- $48.89
- Volume/Avg
- 2,000 / 8,579
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 197
- Website
- https://www.isodiol.com
Valuation
|
Metric
|
ISOLF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ISOLF
Financial Strength
|
Metric
|
ISOLF
|
|---|---|
Quick Ratio | 0.64 |
Current Ratio | 1.16 |
Interest Coverage | −14.75 |
Quick Ratio
ISOLF
Profitability
|
Metric
|
ISOLF
|
|---|---|
Return on Assets (Normalized) | −65.60% |
Return on Equity (Normalized) | −147.29% |
Return on Invested Capital (Normalized) | −85.25% |
Return on Assets
ISOLF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pkhbjjbgqx | Ndn | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Mxnlsdlrsq | Gslbkc | $70.8 Bil | |
HLN
| Haleon PLC ADR | Mgsxmpzd | Rfrb | $37.7 Bil | |
VTRS
| Viatris Inc | Jdpdmhtv | Svhkv | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zlmyksyy | Xskt | $12.5 Bil | |
CTLT
| Catalent Inc | Xwvwbxm | Czxnvt | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Fbbchqcvx | Gpwrm | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Zmxzypbpj | Sxfzd | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ppmtdpnln | Gvkxjv | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Lchzfyhrqc | Wmgjq | $2.9 Bil |